🇺🇸 FDA
Patent

US 11366121

Specific GNAI:GIV interaction screening assays, methods and compositions

granted A61KA61K31/185A61K31/19

Quick answer

US patent 11366121 (Specific GNAI:GIV interaction screening assays, methods and compositions) held by The Regents of the University of California expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/185, A61K31/19, A61K38/17